These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 19875731)
1. The 2009 Feinberg lecture: the continuum of stroke research and policy. Goldstein LB Stroke; 2009 Dec; 40(12):3879-82. PubMed ID: 19875731 [TBL] [Abstract][Full Text] [Related]
3. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect? Allen D; Rixson L Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815 [TBL] [Abstract][Full Text] [Related]
4. Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy? Cui LL; Golubczyk D; Tolppanen AM; Boltze J; Jolkkonen J Ann Neurol; 2019 Jul; 86(1):5-16. PubMed ID: 31020699 [No Abstract] [Full Text] [Related]
5. Optimising outcome assessment to improve quality and efficiency of stroke trials. McArthur K; Fan Y; Pei Z; Quinn T Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):101-11. PubMed ID: 24350886 [TBL] [Abstract][Full Text] [Related]
6. Research without borders: fostering innovative clinical research and implementation. Xian Y; Peterson ED Neurol Res; 2015 Sep; 37(9):840-3. PubMed ID: 25973646 [TBL] [Abstract][Full Text] [Related]
7. The future of basic science research and stroke: hubris and translational stroke research. Lyden P Int J Stroke; 2011 Oct; 6(5):412-3. PubMed ID: 21951405 [No Abstract] [Full Text] [Related]
8. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736 [TBL] [Abstract][Full Text] [Related]
9. The 2008 William M. Feinberg lecture: prioritizing stroke research. Johnston SC Stroke; 2008 Dec; 39(12):3431-6. PubMed ID: 18818399 [TBL] [Abstract][Full Text] [Related]
10. The future of restorative neurosciences in stroke: driving the translational research pipeline from basic science to rehabilitation of people after stroke. ; Cheeran B; Cohen L; Dobkin B; Ford G; Greenwood R; Howard D; Husain M; Macleod M; Nudo R; Rothwell J; Rudd A; Teo J; Ward N; Wolf S Neurorehabil Neural Repair; 2009 Feb; 23(2):97-107. PubMed ID: 19189939 [TBL] [Abstract][Full Text] [Related]
11. Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes. Tanniou J; van der Tweel I; Teerenstra S; Roes KC BMC Med Res Methodol; 2016 Feb; 16():20. PubMed ID: 26891992 [TBL] [Abstract][Full Text] [Related]
12. American Society of Clinical Oncology policy statement: oversight of clinical research. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281 [TBL] [Abstract][Full Text] [Related]
13. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Matza LS; Patrick DL; Riley AW; Alexander JJ; Rajmil L; Pleil AM; Bullinger M Value Health; 2013 Jun; 16(4):461-79. PubMed ID: 23796280 [TBL] [Abstract][Full Text] [Related]
15. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review. Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062 [TBL] [Abstract][Full Text] [Related]
16. Methods to assess adverse health-related outcomes in cancer survivors. Oeffinger KC; van Leeuwen FE; Hodgson DC Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2022-34. PubMed ID: 21980010 [TBL] [Abstract][Full Text] [Related]
17. A research roadmap for complementary and alternative medicine - what we need to know by 2020. Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850 [TBL] [Abstract][Full Text] [Related]
18. The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents. Cramer SC; Koroshetz WJ; Finklestein SP Stroke; 2007 Apr; 38(4):1393-5. PubMed ID: 17332455 [TBL] [Abstract][Full Text] [Related]
19. Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report. Berger ML; Dreyer N; Anderson F; Towse A; Sedrakyan A; Normand SL Value Health; 2012; 15(2):217-30. PubMed ID: 22433752 [TBL] [Abstract][Full Text] [Related]
20. Health policy and outcomes research 2004. Matchar DB; Rudd AG Stroke; 2005 Feb; 36(2):225-7. PubMed ID: 15637316 [No Abstract] [Full Text] [Related] [Next] [New Search]